Individuals with TSC are heterozygous for loss-of-function germline mutations in either of the tumor-suppressor genes TSC1 or TSC2, and they can have benign tumors called hamartomas in multiple organs such as the brain, heart, skin, lungs, and kidney [2]. Here, TSC1 is linked to hamartoma.